PrEP-001
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Viral Upper Respiratory Tract Infection
Conditions
Viral Upper Respiratory Tract Infection
Trial Timeline
Apr 6, 2016 → Sep 30, 2016
NCT ID
NCT03338556About PrEP-001
PrEP-001 is a phase 2 stage product being developed by hVIVO for Viral Upper Respiratory Tract Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT03338556. Target conditions include Viral Upper Respiratory Tract Infection.
What happened to similar drugs?
1 of 6 similar drugs in Viral Upper Respiratory Tract Infection were approved
Approved (1) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03338556 | Phase 2 | Completed |
| NCT03220048 | Phase 2 | Completed |
Competing Products
17 competing products in Viral Upper Respiratory Tract Infection